Evoke Pharma Inc. (EVOK)

NASDAQ: EVOK · Real-Time Price · USD

2.90

0.15 (5.45%)

At close: May 01, 2025, 3:59 PM

3.00

3.42%

After-hours: May 01, 2025, 05:25 PM EDT

Evoke Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-5.35M	-7.79M	-8.22M	-8.54M	-13.15M	-7.13M	-7.57M	-12.23M	-10.75M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	773.12K	1.13M	1.46M	1.88M	1.63M	1.37M	1.54M	1.82M	1.71M
Other Working Capital	n/a	1.14M	505.61K	-4.84M	112.99K	-116.68K	-78.17K	24.66K	554.01K
Other Non-Cash Items	-879.67K	129.07K	37.02K	-75.13K	1.45M	1.37M	-433.39K	1.01M	56.97K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	n/a	1.55M	132.41K	-5.62M	4.9M	-10.4K	-518.56K	687.83K	277.3K
Operating Cash Flow	-5.46M	-4.98M	-6.6M	-12.35M	-6.63M	-5.76M	-6.98M	-8.72M	-8.71M
Capital Expenditures	n/a	-3	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	5.1M	n/a	n/a	n/a	-4.5M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	7.6M	-119.3K	-148.99K	-1.27M	3.93M	n/a	n/a	n/a	n/a
Financial Cash Flow	14.32M	-119.3K	7.29M	13.43M	9.04M	6.11M	4.62M	7.39M	9.02M
Net Cash Flow	8.86M	-5.1M	698.99K	1.08M	2.41M	344.83K	-2.36M	-1.33M	315.92K
Free Cash Flow	-5.46M	-4.98M	-6.6M	-12.35M	-6.63M	-5.76M	-6.98M	-8.72M	-8.71M